Skip to main content
Clinical Trials/NCT01494116
NCT01494116CompletedNot Applicable

Factors Affecting Pediatric Isotonic Fluid Resuscitation Efficiency: Impact of Syringe Size

McMaster Children's Hospital1 site in 1 country48 target enrollmentStarted: October 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
48
Locations
1
Primary Endpoint
Total Intervention Time

Study Overview

Brief Summary

The purpose of this study is to determine the impact of syringe size on the amount of time it takes a health care provider to administer a known volume (900 mL) of resuscitation fluid to a non-clinical, toddler-sized, model. The investigators hypothesize that syringe size will impact fluid resuscitation time.

Detailed Description

The Surviving Sepsis Guideline for the resuscitation of pediatric septic shock indicates that up to 60 mL/kg of isotonic saline should be administered within the first 15 minutes of resuscitation. There are practical challenges to achieving these benchmarks. Syringes are often used to perform manual fluid resuscitation as they are generally available and health care providers are typically comfortable using them. Health care providers have been observed to have different preferences regarding the syringe size used to perform manual fluid resuscitation. Larger syringes e.g. 60 mL-size requires more force to depress the syringe plunger, due to a larger crosssectional area, but fewer syringes are needed to administer a given volume. Fewer syringes results in less time spent connecting and disconnecting syringes, which contributes to total fluid resuscitation time using this technique.

Consenting participants will be randomly assigned (by an independent Randomization Coordinator) to one of four syringe size groups (10 mL, 20 mL, 30 mL, 60 mL sizes). The allocation sequence is therefore concealed. After undergoing a standardization procedure, each participant will be instructed to administer 900 mL of 0.9% normal saline using pre-filled provided syringes by manual push as rapidly as possible using the disconnect-reconnect method. Participants will be advised to consider that they are in a situation where they are resuscitating a 15 kg child (represented by the model) in decompensated shock. Syringes for each 300 mL (20 mL/kg) aliquot will be colour-coded for identification purposes.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Consenting health care staff and health care students capable of performing manual syringe bolus fluid administration

Exclusion Criteria

  • •Non-English speaking individuals
  • •Any condition that would impact upon the individual's ability to perform manual fluid resuscitation e.g. limited hand strength or dexterity

Arms & Interventions

10 mL syringe size

Experimental

Intervention: 900 mL of 0.9% Normal Saline (Other)

20 mL syringe size

Experimental

Intervention: 900 mL of 0.9% Normal Saline (Other)

30 mL syringe size

Experimental

Intervention: 900 mL of 0.9% Normal Saline (Other)

60 mL syringe size

Experimental

Intervention: 900 mL of 0.9% Normal Saline (Other)

Outcomes

Primary Outcomes

Total Intervention Time

Time Frame: From Date of Subject Randomization until Date Intervention Completed (Day 1)

Subject is randomized and the intervention is performed the same day. Start Intervention Time (time zero): Subject begins administering the intervention; End Intervention Time: Subject has completed the intervention (900 mL of Saline has been administered); Total Intervention Time = End Intervention Time - Start Intervention Time. All testing is being video recorded. A blinded outcome assessor will review the video tapes and based upon clear, a priori defined, definitions will determine the Start Intervention Time and the End Intervention Time for each subject.

Secondary Outcomes

  • Time to administer each of three sequential 300 mL fluid boluses(From Date of Subject Randomization until Date Intervention Completed (Day 1))
  • Amount of normal saline actually administered to the model(From Date of Subject Randomization until Date Intervention Completed (Day 1))
  • The proportion of subjects in each group that dislodge the IV catheter during testing.(From Date of Subject Randomization until Date Intervention Completed (Day 1))
  • Self-reported comfort of health care providers while performing the study intervention(From Date of Subject Randomization until Date Intervention Completed (Day 1))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Melissa J Parker, MD, MSc

Assistant Professor

McMaster Children's Hospital

Study Sites (1)

Loading locations...

Similar Trials